QT
STLN

Quantbot Technologies’s Starling Oncology STLN Stock Holding History

Quantbot Technologies’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,455
Closed -$29K – 2250
2026
Q1 		$29K Buy
+9,455
New +$29K ﹤0.01% 1468
2025
Q4 		– Sell
-4,926
Closed -$17.2K – 2172
2025
Q3 		$17.2K Buy
+4,926
New +$16.9K ﹤0.01% 1610

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Quantbot Technologies's STLN Position: Q2 2026 in Review

Quantbot Technologies sold out of Starling Oncology (STLN) in Q2 2026, closing a stake of 9,455 shares — an estimated $29K sold.

Quantbot Technologies first reported a position in STLN in Q3 2025 and held it in 2 quarters. The position peaked at $29K in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Quantbot Technologies reported no remaining Starling Oncology position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 9,455 Starling Oncology shares in Q2 2026, an estimated $29K.
  • Quantbot Technologies first reported a position in Starling Oncology in Q3 2025 and held it in 2 quarters.
  • Quantbot Technologies's Starling Oncology position peaked at $29K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.